n High.
Republic of the Philippines rom re
OFFICE OF THE PRESIDENT & ‘
COMMISSION ONHIGHEREDUCATION =| OEE IS'AE
‘G, CHD Central OMtice CF
CHED MEMORANDUM ORDER (CMO)
No, 18.
Series of 2018
SUBJECT: THE IMPLEMENTING GUIDELINES FOR THE CONDUCT OF DRUG
TESTING OF STUDENTS IN ALL HIGHER EDUCATION
INSTITUTIONS (HEIs)
In accordance with Section 8 (n) and (0) of RA 7722, the Higher Education Act
of 1994 as amended, in relation to Section 36 (c) of RA 9165, the Comprehensive
Dangerous Drugs Act of 2002, and pursuant to Commission en banc Resolution No.
§39-2017 dated 18 July 2017, the Commission issues this “IMPLEMENTING
GUIDELINES FOR THE CONDUCT OF DRUG TESTING OF STUDENTS IN ALL
HIGHER EDUCATION INSTITUTION (HEIs).”
RULE!
RATIONALE AND BACKGROUND
Section 1. The drug problem in the Philippines continues to remain a serious national
concern that permeates both the public and private sectors not only as a security issue,
but also as a health concern that affects the social, emotional, psychological, as well
as the economic well-being of the citizenry.
The Philippine Government recognizes the complimentary roles of public and private
higher education institutions (HEls) and shall exercise reasonable supervision and
regulation thereof. Thus, all HEIs are enjoined to include in their student's handbook
the conduct of mandatory random drug testing of students, with notice to the parents.
Aside from random drug testing, a Higher Education Institution may, within’ the
parameters of its institutional academic freedom, also include in its Student's
Handbook a policy for the conduct of mandatory drug testing as a requirement for
admission and retention, after observance of the consultation and other similar
requirements.
RULE Il
STATEMENT OF POLICIES
Section 2. The State recognizes the primary responsibility of the family and the
complimentary role of the educational institutions and parents for the education and
awareness of its members on the ill-effects of dangerous drugs;
2.1. It is a government policy to foster a spirit of shared purposes and
cooperation among the members and elements of the educational
community and between the community and other sectors of society at
Higher Education Development Center Building, C-P. Garicia Ave., UP Campus, Diliman, Quezon City, Philippines
Web Site: www.ched gov.ph Tel. Nos. 441-1177, 385-4391, 441-1169, 441-1149, 441-1170, 441-1216, 392-5296, 441-1220
441-1228, 988-0002, 441-0750, 441-1254, 441-1235, 441-1255, 411-8910, 441-1171, 362-187122
23.
24
25.
26.
all times. Only in such atmosphere can the true goals and objectives of
education be fulfilled,
The Commission on Higher Education (CHED), as part of its mandate,
has the duty to continuously monitor the effectiveness of the dangerous
drug abuse prevention program through their respective regional/field
offices and may enlist the assistance of any government agency or
instrumentality to carry out the objectives of the program.
The HEls shall have mechanisms to promote healthy lifestyle such as
but not limited to healthy diet, physical activities and no smoking and
alcoholic drinking environment inside and outside the school campus as
mandated in CHED Memorandum Order (CMO) No. 09, s. 2013.
The CHED recognizes the academic freedom of all HEIs, particularly in
implementing a policy on mandatory random drug testing of their
students or as part of the schools’ admission and retention requirements.
In keeping with the dangerous drug abuse prevention program of the
government, the Local Government Units (LGUs), the Philippine
National Police (PNP), or any authorized law enforcement agency may
carry out any legitimate drug-related operation within the school
premises, provided that the same shall be coordinated to the concerned
HEIs prior to the conduct thereof.
The conduct of random drug testing of students in tertiary schools is
mandatory pursuant to Section 36(c) of RA 9165.
The random drug testing under Dangerous Drug Board (DDB)
Regulation No. 6, s. 2003 and No. 3, s. 2009 shall ensure that such is
implemented for drug prevention and rehabilitation purposes and shall
guarantee and respect the personal privacy and dignity of the students.
The drug test results shall be treated with utmost confidentiality and
cannot be used in any criminal proceedings.
RULE Il
OBJECTIVES
Section 3. These implementing guidelines specifically aim to:
34
3.2
3.3
promote a “drug-free” campus and further the legitimate interest of the
government in preventing and deterring dangerous drug use among the
youth:
instill in the minds of the students that dangerous drugs not only interfere
in their ability to learn but also disrupt the teaching environment;
strengthen the collaborative efforts of concerned agencies (Dangerous
Drugs Board (DDB), Department of Health (DOH), Philippine National
Police (PNP), Philippine Drug Enforcement Agency (PDEA) against the
2
AM
ause of illegal drugs and in the treatment of dangerous drug users and
dependents;
3.4 establish a stronger partnership between the government and the HEIs
in providing programs and activities intended to facilitate the holistic and
well-rounded student development; and
3.5 ensure that the drug testing policies of HEls are reasonable and not
violative of the fundamental rights of the students,
RULE IV
SCOPE AND COVERAGE
Section 4. These implementing guidelines for the conduct of drug testing of students
in all HEIs shall follow the parameters laid down by Republic Act No. 9165, the
Comprehensive Dangerous Drugs of 2002 and its Implementing Rules and
Regulations (IRR), as well as the Dangerous Drugs Board (DDB) Regulation No. 6,
Series of 2003, as amended by Dangerous Drugs Board (DDB) Regulation No. 3,
Series of 2009"
RULE V
DEFINITION OF TERMS
Section 5. For purposes of these guidelines, the following terms are defined as
follows:
5.1 Accreditation — refers to the formal authorization issued by the DOH to
an individual, partnership, corporation or association which has complied
with all licensing requirements (input/structural standards) and
accreditation requirements (process standards and outcome/output
impact standards) as prescribed in the Manual of Operations for Drug
Testing Laboratories issued by the DOH.
5.2Confirmatory drug test — refers to an analytical test using a device, tool
or equipment with a different chemical or physical principle that is more
specific which will validate and confirm the result of the screening test. It
refers to the second or further analytical procedure to more accurately
determine the presence of dangerous drugs in a specimen, which shall
likewise be done by any government laboratory or by privately owned
and operated drug testing laboratories accredited and monitored by the
DOH having confirmatory test capabilities.
5.3Current students — refer to existing and currently enrolled students in
an authorized higher education institution,
5.4Dangerous drugs - include those identified and listed in R.A. 9165 or
the "Comprehensive Dangerous Drugs Act of 2002" and its annexes,
subject to any reclassification, addition or removal of any drug from saidlist by the Dangerous Drugs Board, in accordance with Section 93 of
R.A. No. 9165.
5.5DOH-accredited physician — refers to 2 physician with background
experience on psychological/behavioral medicine whose application has
been approved and duly authorized by the DOH to conduct dependency
examination and treatment on persons believed to be using dangerous
drugs.
5.6 Drug abuser ~ refers to a person who uses or administers to himself or
allows others to administer dangerous drugs to himself without medical
approval. He belongs to any of the three categories:
* The Experimenter — one who, out of curiosity, uses or
administers to himself or allows others to administer to him
dangerous drugs once or a few times;
* The Casual user — one who, from time to time, uses or
administers or allows others to administer to him dangerous drugs
in an attempt to refresh his mind and body or as a form of play,
amusement or relaxation; and
* The Drug dependent — one who regularly consumes or
administers or allows others to administer to him dangerous drugs
and has acquired a marked psychological and/or physical
dependence on the drugs which has gone beyond a state of
voluntary control.
5.7 Drug dependency ~ refers to a state of psychological and/or physical
dependence on drugs arising in a person following the administration or
use of the drug on a periodic and continuous basis.
5.8Drug dependency examination — refers to a procedure conducted by
a DOH-accredited physician to evaluate the extent of drug abuse of a
person and to determine whether he/she is a drug dependent or not,
which includes history taking, intake interview, determination of the
criteria for drug dependency, mental and physical status and the
detection of dangerous drugs in body specimens through laboratory
procedures,
5.9Drug dependent — refers to a person who regularly consumes or
administers or allows others to administer to him dangerous drugs and
has acquired a marked psychological and/or physical dependence on
the drugs which has gone beyond a state of voluntary control.
5.10 “Drug-free” campus — refers to the HEIs with intensive and
unrelenting campaign against drug trafficking and use of dangerous
drugs through an integrated system of planning, implementation and
enforcement of anti-drug policies, programs and projects, as shown by
the following:
+ Non-availability of drug supply;
* Absence of drug user/dependent;
* Absence of drug pusher, and* Existence of drug awareness, preventive education and
information, and other related programs.
5.11 Drug testing — the process undertaken to determine the presence of
dangerous drugs in a person's system, to include both screening test
and confirmatory test.
5.12 Drug Testing Coordinator — refers to the point person, duly appointed
by the head of the HE! tasked with handling drug testing program.
5.13 Higher Education Institutions — refer to an institution of higher
learning primarily offering bachelor and advanced degree programs.
5.14 Interventions — are therapeutic programs appropriate for high-risk
individuals/students who are using dangerous drugs and who need
special assistance to recognize the signs and symptoms of initial drug
use and dependency. It may include corrective or rehabilitative actions
that may take the form of crisis intervention, peer counseling, peer
leadership programs, parent/peer groups, or psychological counseling of
the individual or family level and structured rehabilitation programs. It
may also include medical intervention of the afflicted student whenever
necessary. Four (4) major modalities of intervention that can be given,
as established by the Department of Health (DOH) are: (1) in-patient, (2)
out-patient, (3) recover homes/half-way houses, and (4) community-
based interventions.
5.15 Laboratory — refers to a private or government facility capable of
performing a test on a specimen to determine the presence or absence
of dangerous drugs therein.
5.16 Mandatory drug testing — refers to the compulsory submission of a
student for drug testing in all HEls as required in the schoo'’s student
handbook and with notice to the parents.
5.17 Mandatory Random Drug Testing — refers to the compulsory conduct
of random drug testing of students in all HEIs with each student having
equal chance of being selected for testing.
5.18 Prevention — is the promotion of drug-free lifestyle through strategies
such as advocacy, information, dissemination, and training for capability
building
5.19 Random drug testing — refers to unannounced conduct of actual drug
testing of a student having an equal chance of being selected for testing
5.20 Random selection — refers to the unbiased process of selecting
students who are to undergo drug testing,
5.21 Screening drug test ~ refers to a rapid test performed to establish
potential or presumptive positive result. It refers to the immunoassay test
to eliminate a ‘negative’ specimen, i.e. one without the presence of
5dangerous drugs from further consideration and to identify the
presumptively positive specimen that requires confirmatory test.
5.22 Student-Applicants — refer to students who are applying for
admission to a higher education institution either as freshman or a
transferee of an authorized higher education institution (HE!)
5.23 Tertiary Education ~ refers to the stage of education following the
secondary cycle which subsumes post-secondary non-degree diploma,
TVET and Higher Education programs, including graduate education.
RULE VI
DRUG TESTING OF STUDENTS IN ALL HEIs
Section 8. Pursuant to Section 36 (c) of RA 9165, all HEIs are mandated to implement
a mandatory random drug testing of their students, consistent with these implementing
guidelines and other relevant rules and regulations, after observance of consultation
and other similar requirements. For purposes of this Section, the respective Governing
Boards of all HEIs shall incorporate in the Student's Handbook a policy for the conduct
of mandatory random drug testing of the students including the manner and
procedures thereof in line with the DDB Regulation No. 3, s. 2009, the General
Guidelines for the Conduct of Random Drug Testing of Students for xxx Tertiary
Schools, amending DDB Regulation No. 6, s. 2003.
Section 9. Institutional Policy. The conduct of mandatory random drug testing of
students in all HEls must have prior approval of the school’s governing boards and
passed through the necessary consultation process.
Section 10. Consultation. In the absence of a student council/government in an HEI,
representatives of not more than ten (10) shall be selected by the HEI from the
recognized student organizations to participate in the consultation.
Section 12. The HEIs shall present at the consultation the policy requiring mandatory
random drug testing of students.
Section 13. Consultation Period. The consultation must be completed not later than
the end of February of the Academic Year preceding the year that the intended
mandatory testing will be implemented.
Section 14. Only DOH-accredited drug facility, physician or private medical
practitioners shall conduct the necessary drug testing. If the HEI does not have an
accredited clinic, the HE! should partner with a DOH-accredited drug facility, physician
or private medical practitioners duly accredited to administer drug testing
Section 15. Drug Testing as a requirement for admission and retention. Aside from
mandatory random drug testing, a Higher Education Institution may in the exercise of
its institutional academic freedom include in the Student’s Handbook a policy of
mandatory drug testing of students as part of the school's admission and retention
policies, after observance of consultation and other similar requirements. In case the
drug test yielded positive results, the HE! concerned is not barred from admitting thestudentapplicant, unless there is a valid reason not to admit such student/applicant
‘on grounds other than the positive findings as a result of the drug test.
Section 16. Conditions for Drug Testing as a requirement for admission and rete
All HEIs may implement a mandatory drug testing as part of the school's admission
and retention policy, provided that:
16.1. The mandatory drug testing shall be conducted in the same manner as
the random drug testing under DDB Board Regulation No, 6, s. 2003 and
No. 3, s. 2009;
16.2. Incase the test result is confirmed positive, the Drug Testing Coordinator
shall conduct a conference and inform both the parent and the student
concerned;
16.3. The confirmed positive result shall not be a basis for disciplinary action
unless the student concerned is held liable for some other violations of
the schools’ internal rules and regulations; and
16.4. If the student is found to be drug dependent, the appropriate sanction,
intervention, and/or rehabilitation, shall be imposed in accordance with
the schools’ Student Handbook and other applicable laws, rules and
regulations.
RULE VII
CONFIDENTIALITY CLAUSE
Section 17. All HEIs shall guarantee the strict confidentiality and integrity of the
drug test results
17.1 All records must strictly be held confidential as provided for under the
pertinent provisions of RA 9165. The HEIs should also ensure the
provision of non-discriminatory intervention services
17.2 In relation to Rule Vill hereof, the pertinent provisions of RA No. 10173
otherwise known as the "Data Privacy Act of 2012" and its Implementing
Rules and Regulations (IRR) shall be observed specifically Chapter III of
the Act which pertains to the “Processing of Personal Information” to
protect vital important interests of the data subject, including his life and
health
RULE VIII
SANCTIONS
Section 18. In order to ensure compliance with this CMO, the Commission en bane
may, upon the recommendation of CHED Legal and Legislative Services (LLS),
impose appropriate sanctions depending on the nature and seriousness of the
violations thereof, in accordance with applicable laws, rules and regulations.Section 19. Any member of the faculty, administrator, or employee of the HE! who
violates the rules of confidentiality of the results of the drug tests shall, in addition to
the sanctions provided in the school policy, be liable under Section 72 of RA No. 9165
and other applicable laws.
Section 20. The refusal of the student to undergo drug testing under this CMO shall
be subject to appropriate actions in accordance with the schools’ Student Handbook,
provided that in no case shall such refusal to undergo drug testing give rise to a
presumption of drug use or dependency.
RULE IX
MONITORING AND REPORTING
The implementation of this CMO shall be periodically monitored by the concerned
CHED Regional Offices (CHEDROs) which shall thereafter submit a corresponding
report to CHED Central Office (CHED-CO) to ensure that the goal for a “drug-free”
environment in the campus is met
Section 21. Higher Education Institutions (HEIs)
21.1. For regulatory purposes, subject to the provisions of the Data Privacy
Act of 2012 and its Implementing Rules and Regulations (IRR), all HEIs
shall submit to CHEDROs a compliance report on the drug testing
activities conducted on the students, indicating the names and number
of students who have already undergone testing, including among others
the names of the drug testing laboratories that conducted the test, as
well as the summary of the drug test results
21.2. All HEIs shall establish a Drug-Free Committee (DFC) which shall
formulate their internal drug testing rules, which shall provide among
others, the drug education/awareness, prevention and control initiatives.
21.3 The HEls through the Drug-Free Committee (DFC) shall monitor their
students to protect them from engaging in dangerous drug-related
activities, as well as those undergoing interventions, treatment or
rehabilitation
21.4 The HE! shall designate the head of the DFC and the drug testing
coordinator (DTC) who shall implement the drug testing program in the
campus. The names and composition of the DFC shall be submitted to
CHEDROs.
21.4.1 The DFC shall have the following responsibilities:
1. Compose the Selection board for the conduct of the drug testing in
the campus, with representation from the students, faculty and
parents as members.
2. Closely coordinate with the concerned agencies to access official list
of DOH-accredited drug facilities, physicians or private medical
8practitioners duly accredited to administer drug testing, and to
establish appropriate institution-level interventions if needed.
3. Ensure the confidentiality and integrity of the drug test results and
handles the reportorial requirements and any relevant information for
submission to the CHEDROs.
4. Recommend to the school’s governing board the appropriate
interventions, depending on the results of the drug testing
5. The DFC and the Guidance Counselors of HEIs shall be trained for
the purpose of enhancing their skills in handling the problems on
dangerous drug abuse.
RULE X
THE IMPLEMENTATION AND REPORTORIAL REQUIREMENTS UNDER THESE,
GUIDELINES
Section 22. All heads of public and private HEIs, in collaboration with the concerned
CHEDROs, shall ensure and oversee the implementation of Mandatory Random Drug
Testing in accordance with these Guidelines.
Section 23. The CHEDROs shall prepare and submit reports annually, or at any time
if needed, to the Office of Student Development and Services (OSDS) through the
Office of the Executive Director (OED) on the implementation of this CMO.
Section 24. The CHEDROs are mandated to disseminate these implementing
guidelines to the HEIs, conduct schoo! visits, and monitor the conduct of actual drug
testing
RULE XI
FEE REQUIREMENT
Section 25. In relation to this CMO, all fees shall be in accordance with pertinent DOH
and DDB rules and regulations.
Section 26. The fee for drug testing prior to admission will be borne by the student-
applicant. The student-applicant may choose to be tested in any DOH-accredited drug
facility or in the authorized facility of the HEI if any,
Section 27. In cases of drug testing in DOH-accredited HE! Clinic, the HEI may
determine the permissible rate for the drug testing fee, in accordance with the DDB
Regulation No. 01, s. 2004 entitled “Prescribed Drug Test Fee for Government-Owned
and Private Drug Testing Laboratories Accredited by the Department of Health” and
DDB Regulation No. 09, s. 2007 “Amending Board Regulation No. 01, s. 2004."RULE XI
EFFECTIVITY
Section 30. This CMO shall take effect beginning Academic Year (AY) 2019-2020,
after fifteen (15) days of its publication in the Official Gazette or in newspaper of
general circulation. The required copies of this CMO shall be filed with the Office of
the National Administrative Register (ONAR) of the U.P. Law Center. This CMO shall
remain in force and effect until revoked or amended.
RULE XIII
TRANSITORY PROVISION
Section 31. All existing Higher Education Institutions (HEIs) shall be required to fully
comply with the provisions of this CMO beginning Academic Year (AY) 2019-2020. A
Higher Education Institution (HEI) operating after the start of AY 2019-2020 shall
‘comply with the provisions of this CMO, within one (1) year after the start of the school
year of its operation.
Issued this October 26, 2018, Quezon City, Philippines.
For the “qe
J. PROSPERO E. DE VERA Ill, DPA
Chairperson J
10